Biomerica Inc
BMRANasdaqCIK 73290HealthcareFiscal year ends May 31
Reports and events: 162 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1621:00 ET | DEF 14A | Proxy statementPeriod 2026-10-16 | 0001493152-26-047438 |
| 2026-10-1521:00 ET | 10-Q | Quarterly reportPeriod 2026-08-31 | 0001493152-26-047271 |
| 2026-10-1521:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-26-047270 |
| 2026-09-2821:00 ET | 10-K/A | Annual report, amendedPeriod 2026-05-31 | 0001493152-26-044621 |
| 2026-08-3121:00 ET | 10-K | Annual reportPeriod 2026-05-31 | 0001493152-26-040851 |
| 2026-08-2821:20 ET | SCHEDULE 13D | Ownership report, active investor | 0001213900-26-095193 |
| 2026-08-2620:54 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-040251 |
| 2026-06-0420:45 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-26-027290 |
| 2026-04-1321:15 ET | 10-Q | Quarterly reportPeriod 2026-02-28 | 0001493152-26-016388 |
| 2026-01-1422:15 ET | 10-Q | Quarterly reportPeriod 2025-11-30 | 0001493152-26-002286 |
| 2025-12-1613:19 ET | 8-K | 5.07 Shareholder vote results | 0001493152-25-027891 |
| 2025-10-2021:05 ET | DEF 14A | Proxy statementPeriod 2025-12-12 | 0001493152-25-018668 |
| 2025-10-1421:11 ET | 10-Q | Quarterly reportPeriod 2025-08-31 | 0001493152-25-018043 |
| 2025-10-0812:19 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-017363 |
| 2025-09-2621:16 ET | 10-K/A | Annual report, amendedPeriod 2025-05-31 | 0001493152-25-015785 |
| 2025-08-2921:10 ET | 10-K | Annual reportPeriod 2025-05-31 | 0001641172-25-026041 |
| 2025-06-0613:29 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-013942 |
| 2025-04-1613:00 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-004976 |
| 2025-04-1420:15 ET | 10-Q | Quarterly reportPeriod 2025-02-28 | 0001641172-25-004571 |
| 2025-01-1422:06 ET | 10-Q | Quarterly reportPeriod 2024-11-30 | 0001493152-25-002209 |
| 2024-12-1722:00 ET | 8-K | 5.07 Shareholder vote results | 0001493152-24-050432 |
| 2024-11-0622:20 ET | 8-K | 3.01 Delisting notice | 0001493152-24-043867 |
| 2024-10-1521:00 ET | 10-Q | Quarterly reportPeriod 2024-08-31 | 0001493152-24-041156 |
| 2024-09-3021:00 ET | DEF 14A | Proxy statementPeriod 2024-09-30 | 0001493152-24-038820 |
| 2024-08-2821:00 ET | 10-K | Annual reportPeriod 2024-05-31 | 0001493152-24-034208 |
| 2024-06-2821:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-24-025656 |
| 2024-05-1021:15 ET | 8-K | 1.01 Entry into a material agreement; 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001493152-24-018697 |
| 2024-04-1221:00 ET | 10-Q | Quarterly reportPeriod 2024-02-29 | 0001493152-24-014474 |
| 2024-01-1612:00 ET | 10-Q | Quarterly reportPeriod 2023-11-30 | 0001493152-24-002331 |
| 2023-12-1122:19 ET | 8-K | 5.07 Shareholder vote results | 0001493152-23-044431 |
| 2023-10-1221:15 ET | 10-Q | Quarterly reportPeriod 2023-08-31 | 0001493152-23-037070 |
| 2023-09-2721:15 ET | DEF 14A | Proxy statementPeriod 2023-09-27 | 0001493152-23-034447 |
| 2023-09-1917:20 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-033030 |
| 2023-08-2812:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-23-030303 |
| 2023-08-2521:00 ET | 10-K | Annual reportPeriod 2023-05-31 | 0001493152-23-030254 |
| 2023-07-2620:46 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001513162-23-000117 |
| 2023-04-2513:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001513162-23-000074 |
| 2023-04-1420:48 ET | 10-Q | Quarterly reportPeriod 2023-02-28 | 0001513162-23-000067 |
| 2023-03-0721:46 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001513162-23-000034 |
| 2023-03-0214:23 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001513162-23-000023 |
| 2023-02-0714:14 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001513162-23-000015 |
| 2023-01-1321:55 ET | 10-Q | Quarterly reportPeriod 2022-11-30 | 0001513162-23-000005 |
| 2022-12-2921:28 ET | 8-K/A | 5.07 Shareholder vote results | 0001513162-22-000153 |
| 2022-12-1621:35 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001513162-22-000148 |
| 2022-12-1621:20 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001513162-22-000147 |
| 2022-12-0921:07 ET | 8-K | 5.07 Shareholder vote results | 0001513162-22-000140 |
| 2022-12-0921:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001513162-22-000139 |
| 2022-11-1414:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001513162-22-000131 |
| 2022-10-1320:12 ET | 10-Q | Quarterly reportPeriod 2022-08-31 | 0001513162-22-000122 |
| 2022-09-2720:00 ET | DEF 14A | Proxy statementPeriod 2022-12-07 | 0001513162-22-000119 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:53 ET. Listed shows no prices and gives no investment advice.